YIH
TSBX

Y-Intercept (HK)’s Turnstone Biologics TSBX Stock Holding History

Y-Intercept (HK)’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,771
Closed -$93.7K – 1810
2024
Q2 		$93.7K Buy
+35,771
New +$102K 0.01% 1264

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Y-Intercept (HK)'s TSBX Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Turnstone Biologics (TSBX) in Q3 2024, closing a stake of 35,771 shares — an estimated $93.7K sold.

Y-Intercept (HK) first reported a position in TSBX in Q2 2024 and held it in 1 quarter. The position peaked at $93.7K in Q2 2024. 24 funds tracked by Wall St. Rank hold TSBX as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Turnstone Biologics position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 35,771 Turnstone Biologics shares in Q3 2024, an estimated $93.7K.
  • Y-Intercept (HK) first reported a position in Turnstone Biologics in Q2 2024 and held it in 1 quarter.
  • Y-Intercept (HK)'s Turnstone Biologics position peaked at $93.7K in Q2 2024.
  • 24 funds tracked by Wall St. Rank held Turnstone Biologics as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.